|
| 36383730 | Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in children with SCD: a V114-023 (PNEU-SICKLE) study. | Blood Adv | 2023 |
| 37458568 | Return visit rates after an emergency department discharge for children with sickle cell pain episodes. | Pediatr Blood Cancer | 2023 |
| 36821183 | Hydroxyurea: how much is enough? | Blood | 2023 |
| 36715063 | Implementation of CYP2D6-guided opioid therapy at Cincinnati Children's Hospital Medical Center. | Am J Health Syst Pharm | 2023 |
| 36794731 | Using the consolidated framework for implementation research to identify recruitment barriers and targeted strategies for a shared decision-making randomized clinical trial in pediatric sickle cell disease. | Clin Trials | 2023 |
| 36594493 | Iron status and burden of anemia in children with recessive dystrophic epidermolysis bullosa. | Pediatr Dermatol | 2023 |
| 35175326 | Reproductive equity: preserve the reserve. | Blood | 2022 |
| 35836401 | Early hydroxyurea use is neuroprotective in children with sickle cell anemia. | Am J Hematol | 2022 |
| 35857896 | Early initiation of disease-modifying therapy can impede or prevent diffuse myocardial fibrosis in sickle cell anemia. | Blood | 2022 |
| 35686738 | New therapeutics for children with sickle cell disease: A time for celebration, caution, or both? | Pediatr Blood Cancer | 2022 |
| 35319512 | An Immersive Virtual Reality Curriculum for Pediatric Hematology Clinicians on Shared Decision-making for Hydroxyurea in Sickle Cell Anemia. | J Pediatr Hematol Oncol | 2022 |
| 34227124 | Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemia. | Br J Haematol | 2021 |
| 33742510 | Implementation of near-universal hydroxyurea uptake among children with sickle cell anemia: A single-center experience. | Pediatr Blood Cancer | 2021 |
| 33877274 | Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial. | JAMA | 2021 |
| 33841173 | Automated Oxygen Gradient Ektacytometry: A Novel Biomarker in Sickle Cell Anemia. | Front Physiol | 2021 |
| 33534136 | Hydroyxurea improves cerebral oxygen saturation in children with sickle cell anemia. | Am J Hematol | 2021 |
| 34859003 | Clinical Utility of the Addition of Molecular Genetic Testing to Newborn Screening for Sickle Cell Anemia. | Front Med (Lausanne) | 2021 |
| 34591098 | Increased oxygen affinity: to have and to hold. | Blood | 2021 |
| 34020272 | Rapid and automated quantitation of dense red blood cells: A robust biomarker of hydroxyurea treatment response. | Blood Cells Mol Dis | 2021 |
| 34018965 | Engaging Caregivers and Providers of Children With Sickle Cell Anemia in Shared Decision Making for Hydroxyurea: Protocol for a Multicenter Randomized Controlled Trial. | JMIR Res Protoc | 2021 |
| 33949674 | Mobile health use predicts self-efficacy and self-management in adolescents with sickle cell disease. | Transl Behav Med | 2021 |
| 30499909 | Disease Self-Efficacy and Health-Related Quality of Life in Adolescents With Sickle Cell Disease. | J Pediatr Hematol Oncol | 2020 |
| 32019991 | Left atrial dysfunction in sickle cell anemia is associated with diffuse myocardial fibrosis, increased right ventricular pressure and reduced exercise capacity. | Sci Rep | 2020 |
| 31985279 | L-glutamine for sickle cell disease: Knight or pawn? | Exp Biol Med (Maywood) | 2020 |
| 32064363 | Clinical Utility of Confirmatory Genetic Testing to Differentiate Sickle Cell Trait from Sickle-β<sup>+</sup>-Thalassemia by Newborn Screening. | Int J Neonatal Screen | 2020 |
| 33246482 | Hydroxyurea Optimization through Precision Study (HOPS): study protocol for a randomized, multicenter trial in children with sickle cell anemia. | Trials | 2020 |
| 32945013 | Severe infusion-related reaction to crizanlizumab in an adolescent with sickle cell disease. | Am J Hematol | 2020 |
| 32697889 | Improving self-management in adolescents with sickle cell disease. | Pediatr Blood Cancer | 2020 |
| 32147073 | Vitamin D supplementation and pain-related emergency department visits in children with sickle cell disease. | Complement Ther Med | 2020 |
| 32165646 | Author Correction: Left atrial dysfunction in sickle cell anemia is associated with diffuse myocardial fibrosis, increased right ventricular pressure and reduced exercise capacity. | Sci Rep | 2020 |
| 30969263 | Non-transfusion-dependent β-Thalassemia Because of a Single β-Thalassemia Mutation and Coinherited α-Globin Gene Triplication: Need for Increased Awareness to Prevent Incorrect and Delayed Diagnosis. | J Pediatr Hematol Oncol | 2020 |
| 30467830 | The Case for Pharmacogenetics-Guided Prescribing of Codeine in Children. | Clin Pharmacol Ther | 2019 |
| 31045421 | A preliminary investigation of the psychometric properties of PROMIS® scales in emerging adults with sickle cell disease. | Health Psychol | 2019 |
| 31095774 | Hemoglobin Southampton complicated by cerebral ischemia, moyamoya, and hydroxyurea-induced methemoglobinemia. | Am J Hematol | 2019 |
| 31038282 | Hydroxyurea for children with sickle cell anemia: Prescribe it early and often. | Pediatr Blood Cancer | 2019 |
| 30789459 | Parent and Guardian Knowledge of Hematopoietic Cell Transplantation as a Treatment Option for Sickle Cell Disease. | J Pediatr Hematol Oncol | 2019 |
| 31106898 | Robust clinical and laboratory response to hydroxyurea using pharmacokinetically guided dosing for young children with sickle cell anemia. | Am J Hematol | 2019 |
| 30290004 | Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test. | Am J Hematol | 2019 |
| 30339657 | Acceptability and Feasibility of a Disease-specific Patient Portal in Adolescents With Sickle Cell Disease. | J Pediatr Hematol Oncol | 2019 |
| 29330401 | Successful management of concurrent acquired hemophilia A and a lupus anticoagulant in a pediatric hematopoietic stem cell transplant patient. | Bone Marrow Transplant | 2018 |
| 29895661 | l-Glutamine for sickle cell anemia: more questions than answers. | Blood | 2018 |
| 30337320 | Silent cerebral infarction: supply and demand. | Blood | 2018 |
| 29781568 | Diastolic dysfunction is associated with exercise impairment in patients with sickle cell anemia. | Pediatr Blood Cancer | 2018 |
| 29470624 | Measuring liver T2* and cardiac T2* in a single acquisition. | Abdom Radiol (NY) | 2018 |
| 29369491 | Glucose-6-phosphate dehydrogenase deficiency in internationally adopted children. | Pediatr Blood Cancer | 2018 |
| 29210095 | Hereditary xerocytosis: Diagnostic considerations. | Am J Hematol | 2018 |
| 29260287 | Change in liver, spleen and bone marrow magnetic resonance imaging signal intensity over time in children with solid abdominal tumors. | Pediatr Radiol | 2018 |
| 27766637 | Increased prevalence of potential right-to-left shunting in children with sickle cell anaemia and stroke. | Br J Haematol | 2017 |
| 29127677 | Current Standards of Care and Long Term Outcomes for Thalassemia and Sickle Cell Disease. | Adv Exp Med Biol | 2017 |
| 28507082 | Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia. | Blood | 2017 |